Sign in Pull a receipt

CRDF

Cardiff Oncology, Inc.

Healthcare · Biotechnology

$104.70 sample

+1.51 (+1.46%) 1D

Market cap

$282.8B

Price as of

2026-10-29

Latest filing

8-K

Alerts

8

Price$104.70 -0.78% 3M daily closessample

106.0196.54

2026-08-032026-08-252026-09-162026-10-072026-10-29

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 26INSInsider sell: 10% owner
Oct 15INSInsider buy: EVP, Operations
Oct 08INSInsider buy: Chief Financial Officer
Oct 05INSInsider sell: EVP, Operations
Sep 24INSInsider sell: EVP, Operations
Sep 21INSInsider sell: Chief Financial Officer
Sep 16INSInsider sell: Director
Sep 08INSInsider sell: Chief Executive Officer

Sign up to see the real CRDF record →

Company facts

SEC EDGAR registration

Name: Cardiff Oncology, Inc.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: +43sample, -100 to +100
Reporting currency: USD

Who is positioning in CRDF

sample

Insiders: 20 insider transactions over 90 days, net selling, $892.6M
Congress: 4 members traded over 90 days
Institutions · 13F: 15 funds hold $5.8B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$15.5B +14.8% y/y

Q4 2024Q3 2026

Inventory$9.7B +16.2% y/y

Q4 2024Q3 2026

Accounts receivable$6.9B +11.2% y/y

Q4 2024Q3 2026

Total debt$19.3B +12.0% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $138.7B +9.2% 3M
Sample peer B: $106.3B +2.5% 3M
Sample peer C: $74.4B -12.7% 3M
Sample peer D: $134.4B +0.1% 3M
Sample peer E: $114.0B +8.4% 3M